Hong Wang
Scientist Boehringer Ingelheim
Seminars
Thursday 30th April 2026
Human LiverChip® Platforms Enable Mechanistic Interrogation of Fibrosis & Steatosis in MAFLD & MASH
11:45 am
- We developed 3D perfused LiverChip co‑cultures using human hepatocytes and non‑parenchymal cells to model MAFLD/MASH with physiologic multicellular interactions
- TGFβ induced strong fibrosis, inflammation, and loss of hepatocyte identity, while ALK5 inhibition reversed these effects
- Chronic lipid overload reproduced metabolic stress and MASH‑like transcriptional signatures, demonstrating the model’s utility for studying disease mechanisms and therapeutic interventions.
